Gentrack sinks on profit warning; NZ shares fall overall
New Zealand shares fell, led lower by Gentrack, after the utilities software developer downgraded its earnings and gave a flat outlook for 2020.
Saturday, November 23rd 2019, 11:05AM
by BusinessDesk
The S&P/NZX 50 Index decreased 11.86 points, or 0.1 percent, to 10,946.30. Within the index, 16 stocks fell, 20 rose, and 14 were unchanged. Turnover was $138.7 million.
Gentrack dropped 12.6 percent to $4.50, the lowest close in more than two years, after it said earnings before interest, tax, depreciation and amortisation were below its previous guidance range of $25-26 million in the year ended Sept. 30. The company said the outlook for 2020 was also flat. Some 76,000 shares were traded, less than its 90-day average of 103,000.
"That would be the third downgrade for them," said Peter McIntyre, an investment adviser at Craigs Investment Partners. "It's a growth stock and the market doesn't like those words when they come from a growth company."
Synlait Milk fell 3.8 percent to $9.14. The dairy processor said it planned to raise up to $200 million in a five-year bond issue, which it would use to repay bank debt.
The five-year swap rate closed at 1.21 percent, and McIntyre said Synlait could potentially sell the bonds with a coupon in the mid-3 percent range.
Refining New Zealand fell 2 percent to $1.97 after the Marsden Point refinery operator reported a smaller than usual uplift over Singapore rates in its gross refining margin in September and October. Shareholder and transport fuels retailer Z Energy fell 2.6 percent to $4.90.
McIntyre said the week had been busy with company earnings, annual meetings and potential merger and acquisition activity.
Metlifecare was unchanged at $5.80, having gained 11.1 percent after the board said it had received a sub-par indicative offer from a credible buyer, and was engaging with the party.
Fisher & Paykel Healthcare is due to report first-half earnings next week, and McIntyre said that would be keenly watched given the breathing mask maker was typically conservative in offering guidance. F&P Healthcare declined 1.3 percent to $20.47 today.
A2 Milk posted the biggest gain on the day, up 1.6 percent at $14.94 on a volume of 939,000 shares, more than its 779,000 average. That took its weekly gain to 17 percent. The milk marketing firm upgraded its earnings and margin outlook this week.
Sky Network Television rose from an all-time low, up 1.3 percent at 80 cents.
Kathmandu Holdings increased 0.3 percent to $2.95 after it told shareholders at today's annual meeting that it was trading in line with expectations.
Spark New Zealand was the most traded stock on a volume of 4.3 million shares. It increased 0.1 percent to $4.475. Mercury NZ fell 0.9 percent to $4.66 on a volume of 3.2 million shares and Meridian Energy was down 0.1 percent at $4.315 with 2.9 million shares changing hands.
Of other stocks trading on volumes of more than a million shares, Contact Energy was unchanged at $6.85, Fletcher Building rose 1 percent to $5.28, SkyCity Entertainment Group increased 0.3 percent to $3.89, Infratil advanced 0.6 percent to $4.82 and Kiwi Property Group was up 1 percent at $1.56.
Outside the benchmark index, Eroad decreased 0.6 percent to $3.17 after the telematics firm narrowed its first-half loss on rising revenue. It ticked off a significant milestone in the period by selling 100,000 contracted units and said at its current growth rate, it would reach 250,000 units in five years.
Metro Performance Glass rose 2.9 percent to 35.5 cents after Graham Stuart was appointed a director. The glass products manufacturer is scheduled to report first-half earnings on Monday.
Pacific Edge dropped 13.9 percent to 14.2 cents after the shares resumed trading. It raised $7 million in a placement at 15 cents apiece, and will raise a further $13 million in a rights issue at 10 cents apiece.
« NZ shares fall as US-China trade concerns weigh on markets; Ryman slips | Optimism over US-China trade deal welcomed by the market; Cracks at Metroglass » |
Special Offers
Comments from our readers
No comments yet
Sign In to add your comment
Printable version | Email to a friend |